AI assistant
OptimizeRx Corp — Director's Dealing 2024
May 7, 2024
33090_dirs_2024-05-06_0fed7296-e6eb-4ebd-a4ff-5e65e6f4d02a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2024-03-01
Reporting Person: Silvestro Stephen L (Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-01 | Common Stock | M | 1927 | — | Acquired | 18833 | Direct |
| 2024-03-01 | Common Stock | F | 572 | $15.95 | Disposed | 18261 | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.
F2: A prior Form 4 filed by the Reporting Person failed to carry-forward previously owned shares, resulting in an understatement of the shares beneficially owned by the Reporting Person. The total amount beneficially owned has been adjusted to correct such inadvertent understatement.
F3: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended. The original Form 4 filed by the Reporting Person reporting this transaction overstated the number of shares withheld by the Issuer.